Traversa Therapeutics
San Diego
About Traversa Therapeutics
Traversa Therapeutics, Inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of RNAi Delivery Technologies. The company strives to rapidly advance short interfering RNA (siRNA) platform delivery technologies for use by RNAi therapeutic companies in targeting a wide variety of acute, chronic and infectious human diseases. Traversa is focused on the optimization of this platform delivery technology, as well as advancement of its own therapeutic programs for the treatment of Leukemia and Glioblastoma.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $7.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Apr 2009)
- Website: traversathera.com
- Phone: +1 858-454-8400
Industries & Categories
Biotechnology, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/traversa-therapeutics-3559327 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.